Sheldon Krimsky is Lenore Stern Professor of Humanities and Social Sciences in the Department of Urban & Environmental Policy & Planning in the School of Arts & Sciences and Adjunct Professor of Public Health and Community Medicine in the School of Medicine at Tufts University. www.tufts.edu/~skrimsky. He received his BS and MS in physics from Brooklyn College, CUNY and Purdue University respectively, and an MA and PhD in philosophy at Boston University. His research focuses on the linkages between science/technology, ethics/values, and public policy. He has authored, co-authored or edited 14 books and published over 200 papers and reviews that have appeared in: JAMA, Nature, Nature Genetics, Nature Biotechnology, Nature Medicine, NEJM, American Journal of Bioethics, PLOS ONE among others. His books include Genetic Alchemy; Agricultural Biotechnology & the Environment; Biotechnics & Society, Genetic Justice (Gold Medal winner from Independent Publishers); Hormonal Chaos: The Origins of the Environmental Endocrine Hypothesis and The GMO Deception. His latest book is titled Stem Cell Dialogues: A Philosophical and Scientific Inquiry into Medical Frontiers. Currently, he is completing a book on genetically engineered crops under contract with MIT Press.
Professor Krimsky served on the National Institutes of Health’s Recombinant DNA Advisory Committee from 1978-1981. He was a consultant to the Presidential Commission for the Study of Ethical Problems in Medicine and to the Congressional Office of Technology Assessment. He is Board and Founding member of the Council for Responsible Genetics, Fellow of the AAAS and the Hastings Center. Professor Krimsky also was invited to contribute an amicus brief in a Supreme Court case King v Maryland on forensic DNA.
Professor Krimsky is Associate Editor of Accountability in Research and serves on the editorial board of Ethics in Biology, Engineering, and Medicine, Science, Technology & Human Values, on the International Editorial Advisory Board of New Genetics & Society. He was appointed to PLOS Medicine Advisory Group on Competing Interests.